| 1 |
Elbahrawy A, Atalla H, Alboraie M, Alwassief A, Madian A, El Fayoumie M, Tabll AA, Aly HH. Recent Advances in Protective Vaccines against Hepatitis Viruses: A Narrative Review. Viruses 2023;15. [PMID: 36680254 DOI: 10.3390/v15010214] [Reference Citation Analysis]
|
| 2 |
Crespo J, Cabezas J, Aguilera A, Berenguer M, Buti M, Forns X, García F, García-samaniego J, Hernández-guerra M, Jorquera F, Lazarus JV, Lens S, Martró E, Pineda JA, Prieto M, Rodríguez-frías F, Rodríguez M, Serra MÁ, Turnes J, Domínguez-hernández R, Casado MÁ, Calleja JL. Recomendaciones para el diagnóstico integral de las hepatitis virales crónicas en una única extracción analítica. Gastroenterología y Hepatología 2022. [DOI: 10.1016/j.gastrohep.2022.09.009] [Reference Citation Analysis]
|
| 3 |
Agwamba EC, Louis H, Benjamin I, Apebende CG, Unimuke TO, Edet HO, Udoikono A, Nwagu AD, Adeyinka AS. (E)-2-((3-Nitrophenyl)Diazenyl)-3-Oxo-3-Phenylpropanal: Experimental, DFT Studies, and Molecular Docking Investigations. Chemistry Africa 2022. [DOI: 10.1007/s42250-022-00468-4] [Reference Citation Analysis]
|
| 4 |
Miller RL, Mclaughlin A, Montoya V, Toy J, Stone S, Harding J, Liang RH, Wong J, Barrios R, Montaner JS, Joy JB. Impact of SARS-CoV-2 lockdown on expansion of HIV transmission clusters among key populations: A retrospective phylogenetic analysis. The Lancet Regional Health - Americas 2022. [DOI: 10.1016/j.lana.2022.100369] [Reference Citation Analysis]
|
| 5 |
Ha YP, Sun Y, Wilkinson J, Wang S, Chien L, Wu M, Wang E, Freeland C. Implementation and outcomes of a remote hepatitis B screening program designed to overcome COVID‐19 pandemic‐related disruptions to community‐based screenings for Asians in Greater Philadelphia: A descriptive study. Health Science Reports 2022;5. [DOI: 10.1002/hsr2.761] [Reference Citation Analysis]
|
| 6 |
Asukai Y, Briggs A, Garrison LP, Geisler BP, Neumann PJ, Ollendorf DA. Principles of Economic Evaluation in a Pandemic Setting: An Expert Panel Discussion on Value Assessment During the Coronavirus Disease 2019 Pandemic. Pharmacoeconomics 2021;39:1201-8. [PMID: 34557996 DOI: 10.1007/s40273-021-01088-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
